These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1909360)

  • 1. The release of factor VIII and tissue plasminogen activator can not be blocked by specific antagonists to vasopressin.
    Vilhardt H; Barth T
    J Recept Res; 1991; 11(1-4):239-45. PubMed ID: 1909360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP).
    Kaufmann JE; Vischer UM
    J Thromb Haemost; 2003 Apr; 1(4):682-9. PubMed ID: 12871401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic activity and release of factor VIII by vasopressin analogues.
    Vilhardt H; Barth T; Melin P; Aurell CJ
    Eur J Pharmacol; 1993 Mar; 232(2-3):223-6. PubMed ID: 8467859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia.
    Greer IA; McLaren M; Belch JJ; Lowe GD; Forbes CD
    Haemostasis; 1986; 16(1):15-9. PubMed ID: 3084364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of factor VIII after administration of DDAVP to conscious dogs.
    Vilhardt H; Barth T; Falch J; Nilsson IM
    Thromb Res; 1987 Sep; 47(5):585-91. PubMed ID: 3118500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propranolol, barbiturate anesthesia and splenectomy on factor VIII:C and plasminogen activator release induced by DDAVP. An experimental study on the dog.
    Pina-Cabral JM; Cunha-Monteiro A; Sousa-Dias MC; Andrade JA
    Thromb Haemost; 1989 Sep; 62(2):784-7. PubMed ID: 2510352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
    Castaman G; Lattuada A; Mannucci PM; Rodeghiero F
    Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
    MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P
    Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis.
    Vincente V; Corrales J; Miralles J; Alberca I
    Thromb Res; 1987 Mar; 45(5):695-7. PubMed ID: 3109066
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
    Kinter LB; McConnell I; Goodwin BT; Campbell S; Huffman WF; Arthus MF; Lonergan M; Bichet DG
    J Pharmacol Exp Ther; 1992 May; 261(2):462-9. PubMed ID: 1578361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator enhancing activity of vasopressin analogues in monkeys: structure-activity study.
    Vilhardt H; Barth T
    J Recept Res; 1993; 13(1-4):305-11. PubMed ID: 8450495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII and tissue plasminogen activator in monkeys after administration of DDAVP analogues.
    Vilhardt H; Barth T
    Thromb Res; 1992 Dec; 68(6):501-4. PubMed ID: 1341062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.